We found a unique genomic feature of Chinese metastatic ccRCC patients with a higher prevalence of alterations in DDR, TOP1, and SNCAIP. Further investigated studies and drug development are needed in the future. The gene discussed is TOP1; the disease is nonpapillary renal cell carcinoma.